[Federal Register Volume 61, Number 172 (Wednesday, September 4, 1996)] [Notices] [Page 46632] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-22479] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Pharmacoeconomic Center Notice Regarding Use of Drugs for Unlabeled Applications AGENCY: Department of Defense Pharmacoeconomic Center. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Pharmacoeconomic Center (PEC) announces as a matter of policy that Food and Drug Administration (FDA) approved drugs may be used, where appropriate, for unlabeled indications. It is the further intent of the Department of Defense (DoD) that such drugs may be included, where appropriate, in disease state analyses which may result in their selection to the Tri-Service Formulary and promotion for a given disease state. FOR FURTHER INFORMATION CONTACT: Captain Charles S. Reeves, USN, DoD Pharmacoeconomic Center, Fort Sam Houston, Texas 78234, (210) 221-5596. SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 352(f) et seq., notice is given that pharmacies on DoD installations will, as a matter of policy, fill prescriptions in appropriate cases with drugs that are not necessarily approved by the FDA for the treatment of the underlying medical condition but have nonetheless been proven effective for treatment of the disease state in question. Errol L. Moran, Director, Pharmacoeconomic Center. [FR Doc. 96-22479 Filed 9-3-96; 8:45 am] BILLING CODE 3710-08-M